Track BioGaia AB (publ) — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

BioGaia AB (publ) BIOG-B.ST Open BioGaia AB (publ) in new tab

132.40 SEK
P/E
36.02
EPS
3.29
Yield
1.40%
P/B
9.12
ROE
21.91
Beta
0.31
Loading chart...
Key Metrics
Earnings dateJuly 17, 2026
P/E36.02
EPS3.29
Book Value12.99
Price to Book9.12
Debt/Equity1.76
% Insiders16.058%
Growth
Revenue Growth0.21%
Earnings Growth0.21%
Estimates
Forward P/E27.37
Forward EPS4.33
Dividend
Dividend Yield1.40%
Annual dividends1.64 SEK
Ex-Div. DateMay 8, 2026
Payout59.27%
5y avg Yield1.26%

DCF Valuation

Tweak assumptions to recompute fair value for BioGaia AB (publ) (BIOG-B.ST)
Currency: SEK
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

BioGaia AB (publ) Logo BioGaia AB (publ) Analysis (BIOG-B.ST)

Sweden Health Care Official Website Stock

Is BioGaia AB (publ) a good investment? BioGaia AB (publ) (BIOG-B.ST) is currently trading at 132.40 SEK.

In terms of valuation, the stock trades at a P/E ratio of 36.02. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: BioGaia AB (publ) is expected to release its next earnings report on July 17, 2026. The market consensus estimate for Forward EPS is 4.33.

For income investors, BioGaia AB (publ) pays a dividend yield of 1.40%. With a payout ratio of 59%, the dividend appears sustainable.

Investor FAQ

Does BioGaia AB (publ) pay a dividend?

Yes, it pays an annual dividend of 1.64 SEK (1.40% yield).

What asset class is BioGaia AB (publ)?

BioGaia AB (publ) is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 17, 2026. The company currently has a trailing EPS of 3.29.

Company Profile

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.

Exchange Ticker
STO (Sweden) BIOG-B.ST
Dividend Yield

1.40% (5y avg: 1.26%)

Annual Dividends

1.64 SEK

Next ex. div date

May 8, 2026

Payout Ratio

59.27%

Historical Dividends
Year Total Dividends
2026 4.00 SEK
2025 6.90 SEK
2024 6.90 SEK
2023 2.90 SEK
2022 14.92 SEK
2021 3.41 SEK
2020 3.75 SEK
2019 10.00 SEK
2018 9.00 SEK
2017 7.50 SEK
2016 1.00 SEK
2015 1.00 SEK
2014 1.40 SEK
2013 2.00 SEK
2012 1.20 SEK
2011 0.40 SEK
2010 0.30 SEK
2009 0.08 SEK

Yearly aggregated dividends

Dividends

BioGaia AB (publ)
May 15, 2026 Paid
Dividend
4.0 SEK

Historical Split Corporate Actions

Split Date Split Ratio to 1
May 18, 2022 5.000000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion